Aptevo Therapeutics Inc. (APVO) NASDAQ

0.93

-0.0899(-8.81%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap2.09M
Enterprise Value-2M
P/E Ratio-0.03
PEG Ratio-0
Price/Sales Ratio0
Price/Book Ratio0.11
Enterprise/Revenue0
Enterprise/EBITDA-1.79

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.54
Return On Equity-6.76

Income Statement

Revenue0
Revenue/Share0
Gross Profit-352,000
EBITDA-23.78M
Net Income-24.13M
Diluted EPS-1,747.68

Balance Sheet

Total Cash21.06M
Total Cash/Share12.75
Total Debt3.99M
Total Debt/Equity0.65
Current Ratio2.27
Book Value Per Share8.84

Price History

52-Week Change-99.04
52-Week High109.8
52-Week Low0.91
Moving Average 50 Days1.35
Moving Average 200 Days7.45

Statistics

Average Volume2.11M
Shares Outstanding16.85M
% Held by Institutions15.37

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMay 27, 2025